Induction of CDC2 Phosphorylation in Skin Biopsies from Patients with Solid Tumors Undergoing DNA-Damaging Chemotherapy

Amy Sun
Amy Sun
Raymond L. Lam
Raymond L. Lam
Amy Harman
Amy Harman
Anna C. Pavlick
Anna C. Pavlick
Gary A. Herman
Gary A. Herman
Lisa M. Dauffenbach
Lisa M. Dauffenbach
Christopher A. Kerfoot
Christopher A. Kerfoot
Pearl Huang
Pearl Huang
Jonathan Cheng
Jonathan Cheng
Tim Demuth
Tim Demuth
Robert Iannone
Robert Iannone
Merck & Co., Inc., Rahway, NJ, USA (United States)

Send Message

To: Author

Induction of CDC2 Phosphorylation in Skin Biopsies from Patients with Solid Tumors Undergoing DNA-Damaging Chemotherapy

Article Fingerprint

ReserarchID

E4CZU

Induction of CDC2 Phosphorylation in Skin Biopsies from Patients with Solid Tumors Undergoing DNA-Damaging Chemotherapy Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Font Type
Font Size
Font Size
Bedground

Abstract

This study was to clinically validate phosphorylated CDC2(pCDC2) as a biomarker for Wee1 kinase inhibitors by measuring pCDC2 in skin biopsies from patients receiving DNA damaging chemotherapy. Skin biopsies were performed at scheduled times after chemotherapy. Total CDC2 and pCDC2 in epidermal cells, hair follicle and bulb from skin biopsies were determined using chromogenic multiplex immunohis-tochemistry with multispectral image analysis. Statistical analyses were performed for each cell type after log-transformation of data. Thirty-one patients (29-88 years) completed the study. Significant induction of pCDC2 in response to chemotherapy was detected. Epidermis was most consistently evaluable across skin biopsies, demonstrating strong induction of pCDC2. The percentage of cells positive for total CDC2 and pCDC2 showed a 1.40-fold induction from baseline to 24h post-infusion (p=0.012) and a 2.05-fold increase from baseline to 48h (p

References

12 Cites in Article
  1. Osamu Hashimoto,Masako Shinkawa,Takuji Torimura,Toru Nakamura,Karuppaiyah Selvendiran,Masaharu Sakamoto,Hironori Koga,Takato Ueno,Michio Sata (2006). Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.
  2. H Hirai (2009). Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53deficient tumor cells to DNA-damaging agents.
  3. H Hirai (2010). MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5fluorouracil.
  4. Takumi Kawabe (2004). G2 checkpoint abrogators as anticancer drugs.
  5. S Leijen,J Beijnen,J Schellens (2010). Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNADamaging Agents.
  6. Jun Li,Yuli Wang,Yi Sun,Theodore Lawrence (2002). Wild-Type TP53 Inhibits G<sub>2</sub>-Phase Checkpoint Abrogation and Radiosensitization Induced by PD0166285, a WEE1 Kinase Inhibitor.
  7. S Mizuarai (2009). Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor.
  8. M O'connell,N Walworth,A Carr (2000). The G2-phase DNA-damage checkpoint.
  9. Martin Oken,Richard Creech,Douglass Tormey,John Horton,Thomas Davis,Eleanor Mcfadden,Paul Carbone (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group.
  10. S Paul (2010). How to improve R&D productivity: the pharmaceutical industry's grand challenge.
  11. W Plunkett,P Huang,Y Xu,V Heinemann,R Grunewald,V Gandhi (1995). Gemcitabine: metabolism, mechanisms of action, and selfpotentiation.
  12. Geoffrey Shapiro,J Harper (1999). Anticancer drug targets: cell cycle and checkpoint control.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Amy Sun. 2014. \u201cInduction of CDC2 Phosphorylation in Skin Biopsies from Patients with Solid Tumors Undergoing DNA-Damaging Chemotherapy\u201d. Global Journal of Medical Research - K: Interdisciplinary GJMR-K Volume 14 (GJMR Volume 14 Issue K1).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Version of record

v1.2

Issue date
March 13, 2014

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 4864
Total Downloads: 2501
2026 Trends
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Induction of CDC2 Phosphorylation in Skin Biopsies from Patients with Solid Tumors Undergoing DNA-Damaging Chemotherapy

Amy Sun
Amy Sun <p>Merck & Co., Inc., Rahway, NJ, USA (United States)</p>
Raymond L. Lam
Raymond L. Lam
Amy Harman
Amy Harman
Anna C. Pavlick
Anna C. Pavlick
Gary A. Herman
Gary A. Herman
Lisa M. Dauffenbach
Lisa M. Dauffenbach
Christopher A. Kerfoot
Christopher A. Kerfoot
Pearl Huang
Pearl Huang
Jonathan Cheng
Jonathan Cheng
Tim Demuth
Tim Demuth
Robert Iannone
Robert Iannone

Research Journals